Marco Donia: Practical considerations for best practices to apply TIL therapy
Marco Donia, Senior Consultant at the University of Copenhagen Herlev Hospital, posted on LinkedIn about recent paper by him as co-author, titled “Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment” published on BMJ Journals.
Authors: Simon Turcotte, Marco Donia, Brian Gastman, Michal Besser, Robert Brown, George Coukos, Benjamin Creelan, John Mullinax, Vernon K Sondak, James C Yang, Maartje W Rohaan, Inge Marie Svane, Michael T Lotze, John B A G Haanen, Stephanie L Goff
“Art of TIL (tumor-infiltrating lymphocyte) therapy: Society for Immunotherapy of Cancer (SITC) perspective on demystifying a complex treatment (Free Access on Journal for ImmunoTherapy of Cancer, Jan 20th 2025).
Must read for all those interested in solid tumor cell therapy.
Check our practical considerations for best practices to apply TIL therapy.
Thanks to all coauthors, in particular Simon Turcotte and Stephanie Goff for leading this effort!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023